CLDN News Alert Celladon Corp (CLDN) 17.25 12/12/2014 23:41:

New Post Public Reply Private Reply Replies (0) Message Board

Dec 13, 2014 at 12:41 AM

Celladon Corp (CLDN) 17.25 $CLDN

Celladon Corporation (CLDN) Falls: Stock Goes Down 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 8:09AM CST
Celladon Corporation stock fell nearly 9% last trading session, reversing its recent trend
BIIB: 344.49 (+2.16), ANIP: 54.28 (+2.33), CLDN: 17.25 (+0.75), AFFX: 8.94 (-0.36)

Nasdaq stocks posting largest percentage decreases
AP - Thu Dec 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
UIHC: 19.96 (-0.03), CLDN: 17.25 (+0.75), BRID: 7.50 (+0.49), HCCI: 9.73 (-1.17), MIND: 5.92 (+0.17), ROSE: 18.47 (-1.68), OBAS: 7.98 (-0.23), MEIP: 4.20 (unch), IESC: 7.53 (+0.19), SRPT: 13.97 (-0.33), CONN: 17.44 (+0.35), LINE: 12.01 (-1.32), DGLY: 15.55 (+1.34)

Nasdaq stocks posting largest volume increases
AP - Thu Dec 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
SOFO: 7.74 (-2.37), CLNT: 3.79 (-0.16), WATT: 7.25 (-0.22), MLVF: 11.80 (+0.21), RNST: 28.45 (-0.59), CLDN: 17.25 (+0.75), CYRN: 1.80 (-0.16), AIRT: 23.16 (+0.85), CNTY: 5.04 (+0.05)

Celladon Corp. (CLDN) Jumps: Stock Adds 14.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 7:51AM CST
Celladon Corporation (CLDN) was a big mover last session, as its shares rose almost 15% on the day.
ANIP: 54.28 (+2.33), ILMN: 184.30 (-2.53), CLDN: 17.25 (+0.75), AFFX: 8.94 (-0.36)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:45AM CST

BLUE: 91.28 (+5.16), SC: 17.65 (-0.71), ANV: 0.74 (-0.04), UTIW: 11.07 (-0.33), AKAO: 11.91 (-0.31), CLDN: 17.25 (+0.75), MZOR: 14.30 (+0.10), NBG: 1.79 (-0.01), TTI: 5.06 (-0.34), TPLM: 4.06 (-0.18), CGIX: 6.30 (unch), LCI: 43.58 (-0.46), SAVE: 68.12 (-0.88), PQ: 3.46 (-0.11), AFMD: 5.38 (-0.34), ENSV: 1.48 (-0.02), CTC: 0.77 (+0.01), CONN: 17.44 (+0.35), PDCE: 33.13 (-0.89), KPTI: 34.85 (+1.35)

Celladon Corporation to Present at 11th Global Cardio Vascular Clinical Trial Forum
GlobeNewswire - Mon Dec 01, 3:13PM CST
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that Janice Pogoda, Ph.D., Executive Director of Biostatistics at Celladon, has been selected to present guidance for future clinical trials of therapies for cardiac disease during the 11 Global Cardio Vascular Clinical Trial Forum (CVCT). The presentation will take place during Session 1: The Specific Framework of Cell and Gene Therapy Trials, on Saturday, December 6, 2014 from 11:30 a.m. - 3:00 p.m. EST in Washington D.C.
CLDN: 17.25 (+0.75)

Celladon Selected to Present During the "Best of Circulation Research" Symposium at the American Heart Association Scientific Sessions 2014
GlobeNewswire - Fri Nov 14, 7:00AM CST
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that Krisztina Zsebo, Ph.D., Chief Executive Officer of Celladon, was selected to present three-year long-term follow up data of MYDICAR in patients with advanced heart failure during the "Best of Circulation Research" Symposium at the American Heart Association (AHA) Scientific Sessions 2014 on Sunday, November 16, 2014 in Chicago.
CLDN: 17.25 (+0.75)

Celladon Net loss of $8.35M
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 6:18AM CST

CLDN: 17.25 (+0.75)

Celladon Reports Third Quarter 2014 Financial Results and Recent Highlights
GlobeNewswire - Wed Nov 12, 5:00AM CST
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced financial results for the quarter ended September 30, 2014 and recent corporate highlights and updates.
CLDN: 17.25 (+0.75)

Celladon Corporation to Present at Credit Suisse Healthcare Conference
GlobeNewswire - Fri Nov 07, 3:05PM CST
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that Krisztina Zsebo, Ph.D., Chief Executive Officer, will present a corporate overview at the Credit Suisse Healthcare Conference, being held at the Arizona Biltmore Hotel, Scottsdale, Arizona.
CLDN: 17.25 (+0.75)

Celladon Corporation to Present at Credit Suisse Healthcare Investor Conference
GlobeNewswire - Wed Nov 05, 3:38PM CST
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that Krisztina Zsebo, Ph.D., Chief Executive Officer, will present a corporate overview at the Credit Suisse Healthcare Conference, being held at the Arizona Biltmore Hotel, Scottsdale, Arizona.
CLDN: 17.25 (+0.75)

Lonza and Celladon Corporation Establish a Strategic Commercial Manufacturing Collaboration for MYDICAR(R)
GlobeNewswire - Mon Nov 03, 5:00AM CST
-- Agreement enhances existing relationship between Celladon and Lonza for the manufacture of MYDICAR(R)
CLDN: 17.25 (+0.75)

Larsen MacColl Partners, LP Divests A&S Services Group, LLC
Business Wire - Fri Oct 31, 6:00AM CDT
Larsen MacColl Partners, LP ("LMP"

, announced today that on October 24, 2014 it sold its portfolio company, A&S Services Group, LLC and affiliates (collectively, "A&S"

, to Celadon Group, Inc. The purchase price was $55 million and LMP will realize a 24x multiple of its invested capital from the sale.
CLDN: 17.25 (+0.75)

Celadon Group Reports September Quarter Results and Declares Dividend
PR Newswire - Wed Oct 29, 4:20PM CDT
Celadon Group Inc. (NYSE : CGI) today reported its financial and operating results for the three months ended September 30, 2014, the first quarter of the Company's fiscal year ending June 30, 2015.
CLDN: 17.25 (+0.75), CGI: 21.16 (unch)

Celadon Group Acquires A&S Services Group, LLC
PR Newswire - Mon Oct 27, 1:27PM CDT
Celadon Group, Inc. (NYSE: CGI) "Celadon", one of North America's premier transportation and logistics companies, today announced the acquisition of A&S Services Group, LLC ("A&S"

. A&S is a leading regional for-hire and dedicated truckload carrier based in New Freedom, PA. A&S's fleet operations provide dry van transportation services almost exclusively and principally serve the Mid-Atlantic and Northeast regions. A&S is also a major supplier of logistics, warehousing and distribution services in the area.
CLDN: 17.25 (+0.75), CGI: 21.16 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sunshine Buns Gains Traction with Target Expansion

Frozen cinnamon rolls zapping to perfection in 45 seconds? Someone tell my breakfast table it's about to be revolutionized. Sunshine Buns is taking a giant leap into the spotlight as they hit the shelves of Target stores across the U.S. This isn’t just a nice little upturn—this is a potential game-changer for the frozen pastries aisle. A Sweet Deal Gets Sweeter Now,...

Farizon SV 2027 Debuts in France Amid Market Shifts

A New Entry in the European Delivery Market The game's changing in European delivery, folks, and you better believe Geely Farizon's got a stake in it. Rolling out their all-electric Farizon SV Model Year 2027 at the world-renowned Marché International de Rungis, these folks are nothing if not ambitious. Nestled in the heart of the produce distribution world, Rungis...

Home EV Charging Demands Better Electrical Solutions

Power Plays in the Dallas Electrical Scene There's a new wrinkle for folks in Dallas slapping Level 2 EV chargers onto their garages. Seems like the plug-in station ain’t the only piece of the puzzle, and Safe Plug Electric is pointing its flashlight at a less obvious snag—electrical capacity. They're preaching from Garland to any soul across Dallas and Collin County...

New Ambulatory Surgery Center in Alabama Breaks Ground

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

OLX Rolls Out New AI Tools Amid Trust Issues

A Grounded Approach to AI-Driven Market Evolution OLX Group's stepping into some turbulent waters, folks. They've dropped two new AI-assisted tools, Agentic Selling and DealFinder, while users are still trying to wrap their heads around trusting AI. Now, don't get me wrong, there's potential here—but the road ahead isn't paved with gold just yet. AI-Powered Tools Ready...

BNY's Conference Spotlight: Strategic Moves Ahead?

BNY's CFO to Unpack Strategies at BMO Financials Conference They say you can tell a lot about a company by the folks steering the ship. And let me tell you, folks, Dermot McDonogh from BNY is setting sail over to Boca Raton to spill some beans. November 9 marks the date when BNY’s Chief Financial Officer will stand behind the mic at the BMO Financials Conference at 8:45...

Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Sony's LYTIA 720 Image Sensor: A Game Changer?

Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...

Medical Device Manufacturing: $135B Market by 2031

Skyrocketing Demand in Medical Device Manufacturing You're looking at a market that's gearing up to hit a whopping $135.47 billion by 2031. That's a big leap from its $85.59 billion stature in 2026, showing a strong 9.6% compound annual growth rate (CAGR). Now, if that doesn't get your investor rollercoaster senses tingling, I don't know what will. Key Growth Drivers The...

Ellucian's Cloud Hat-Trick: Leading AI in Education

Turning the Dial on Cloud Innovation What’s gripping the talk of the town? It's the powerhouse, Ellucian, clinching the 2026 Stratus Award for Cloud Computing in the Education category, marking a third straight victory. It’s a trifecta that signals something big in the world of higher ed tech. But what does it mean for investors and the sector at large? Unpacking the...